article thumbnail

Doctors and public health experts join calls for halt to AI R&D until it's regulated

Medical Xpress

An international group of doctors and public health experts have joined the clamor for a moratorium on AI research until the development and use of the technology are properly regulated.

Doctors 94
article thumbnail

Are drug regulators sufficiently independent from the companies they are meant to regulate?

Scienmag

Patients and doctors expect drug regulators to provide an unbiased, rigorous assessment of new medicines before they hit the market.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Regulators questioned integrity of Pfizer/BioNTech vaccine, leaked files show

pharmaphorum

European regulators questioned the integrity of early batches of Pfizer/BioNTech’s mRNA vaccine, although the matter was resolved before approval, according to information leaked online following a cyberattack. The post Regulators questioned integrity of Pfizer/BioNTech vaccine, leaked files show appeared first on.

article thumbnail

UK online doctor firm fined for providing ‘risky’ unlicensed service

pharmaphorum

An online doctor’s service operating in the UK has been fined after pleading guilty to providing online consultation and prescription services without being registered with the Care Quality Commission (CQC). It also concluded that the service was misleading as it suggested the scrips were assessed by doctors in the UK.

Doctors 57
article thumbnail

UK doctors ask for ‘urgent review’ of COVID-19 vaccine second dose delay

BioPharma Reporter

The British Medical Association (BMA), the trade union and professional body for doctors in the UK, is calling for the delay between Pfizer/BioNTech COVID-19 vaccine doses to be reduced from 12 weeks to six weeks.

Doctors 111
article thumbnail

Moderna, citing need for 'flexibility,' seeks broad clearance of fourth COVID shot

Bio Pharma Dive

regulators to authorize another booster shot for people 65 and older, Moderna has followed with a similar request for all adults, arguing a green light would "provide flexibility" to public health officials and doctors. Days after Pfizer asked U.S.

Doctors 152
article thumbnail

FDA to Require Breast Density Notification Amongst Other Updates to Mammography Regulations

FDA Law Blog

By Véronique Li, Senior Medical Device Regulation Expert — Earlier this month, FDA published a final rule to update the mammography regulations, issued under the Mammography Quality Standards Act of 1992 (MQSA) and the Federal Food, Drug, and Cosmetic Act (FD&C Act).